Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Nurix Therapeutics, Inc.
Incyte Corporation
Sotio Biotech Inc.
Symphogen A/S
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
Quadriga Biosciences, Inc.
Xencor, Inc.
Ascentage Pharma Group Inc.
Stony Brook University
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
University of Chicago
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)